Sr. Principal Scientist
Amgen
Thousand Oaks, California
Dr. Omar Barnaby is a Sr. Principal Scientist in the Translational Safety and Bioanalytical Sciences department at Amgen. He provides bioanalytical leadership and oversight for small and large molecule programs and is responsible for the overall conduct of regulated bioanalytical studies that employ LC-MS/MS methodology. Omar is a subject matter expert in quantitative mass spectrometry and serves on several project teams in this capacity at Amgen. His experience includes the development of methods for intact proteins, oligonucleotides, multiplexed biomarkers, and antibody peptide conjugates.
Omar is a graduate of the University of Nebraska – Lincoln (Ph.D. in Chemistry, NE, USA). He completed a Postdoctoral Fellowship at the Harvard Medical School where he used quantitative proteomics to identify dementia biomarker candidates in CSF. Omar has 16 publications, 1 patent, and he currently serves on the AAPS non-liquid matrices team.
Clinical Bioanalysis of AMG 133, a Bispecific Molecule for Obesity
Tuesday, October 24, 2023
3:00 PM – 3:15 PM ET